Your browser doesn't support javascript.
loading
Differences between bipolar disorder types 1 and 2 support the DSM two-syndrome concept.
Tondo, Leonardo; Miola, Alessandro; Pinna, Marco; Contu, Martina; Baldessarini, Ross J.
Afiliación
  • Tondo L; International Consortium for Mood & Psychotic Disorders Research, McLean Hospital, Belmont, MA, United States. Ltondo@aol.com.
  • Miola A; Department of Psychiatry, Harvard Medical School, Boston, MA, United States. Ltondo@aol.com.
  • Pinna M; Lucio Bini Mood Disorder Center, Via Cavalcanti 28, Cagliari, Italy. Ltondo@aol.com.
  • Contu M; International Consortium for Mood & Psychotic Disorders Research, McLean Hospital, Belmont, MA, United States.
  • Baldessarini RJ; Department of Neuroscience, Padova Neuroscience Center, University of Padova, Padua, Italy.
Int J Bipolar Disord ; 10(1): 21, 2022 Aug 03.
Article en En | MEDLINE | ID: mdl-35918560
ABSTRACT

OBJECTIVE:

To compare characteristics of bipolar disorder patients diagnosed as DSM-5 types I (BD-1) vs. II (BD-2).

METHODS:

We compared descriptive, psychopathological, and treatment characteristics in a sample of 1377 consenting, closely and repeatedly evaluated adult BD patient-subjects from a specialty clinic, using bivariate methods and logistic multivariable modeling.

RESULTS:

Factors found more among BD-2 > BD-1 cases included [a] descriptors (more familial affective disorder, older at onset, diagnosis and first-treatment, more education, employment and higher socioeconomic status, more marriage and children, and less obesity); [b] morbidity (more general medical diagnoses, less drug abuse and smoking, more initial depression and less [hypo]mania or psychosis, longer episodes, higher intake depression and anxiety ratings, less mood-switching with antidepressants, less seasonal mood-change, greater %-time depressed and less [hypo]manic, fewer hospitalizations, more depression-predominant polarity, DMI > MDI course-pattern, and less violent suicidal behavior); [c] specific item-scores with initial HDRS21 (higher scores for depression, guilt, suicidality, insomnia, anxiety, agitation, gastrointestinal symptoms, hypochondriasis and weight-loss, with less psychomotor retardation, depersonalization, or paranoia); and [d] treatment (less use of lithium or antipsychotics, more antidepressant and benzodiazepine treatment).

CONCLUSIONS:

BD-2 was characterized by more prominent and longer depressions with some hypomania and mixed-features but not mania and rarely psychosis. BD-2 subjects had higher socioeconomic and functional status but also high levels of long-term morbidity and suicidal risk. Accordingly, BD-2 is dissimilar to, but not necessarily less severe than BD-1, consistent with being distinct syndromes.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Bipolar Disord Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Int J Bipolar Disord Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos